Product
rVSVDG-ZEBOV-GP Ebola Virus Vaccine
1 clinical trial
1 indication
Indication
EbolaClinical trial
An Open-Label, Case-Control Study to Compare the Anamnestic Response to the Recombinant Vesicular Stomatitis Delta Glycoprotein Zaire Ebola Virus (ZEBOV) Glycoprotein (rVSVDG-ZEBOV-GP) Ebola Virus Vaccine Among Ebola Virus Disease Survivors to the Primary Immune Response Among Naïve Age and Sex-Matched ControlsStatus: Not yet recruiting, Estimated PCD: 2025-03-01